Trial Profile
An investigator initiated phase I trial of T-cell receptors (TCRs)
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Cell therapies (Primary)
- Indications Cancer
- Focus Adverse reactions
- 24 May 2016 New trial record
- 18 May 2016 According to a MediGene AG media release, this trial is expected to initiate in the year 2016 or 2017 subject to grant funding.